Liver cancer is one of the most important malignant tumors, ranking third in the mortality rate of malignant tumors. In recent years, its morbidity and mortality have not decreased significantly, so the research task of liver cancer prevention and treatment is arduous. In order to promote the sustainable development of liver cancer prevention and treatment in China, strengthen the standardized diagnosis and treatment of liver cancer, and promote new breakthroughs in the diagnosis and treatment of liver cancer, Chengdu High-tech Medical Association successfully held the Youth and Middle-aged Forum on July 12, 2022.

The conference invited young and middle-aged physicians, physicists and technicians engaged in liver cancer and tumor therapeutics in Chongqing, Guizhou, Guangdong and other places to discuss and exchange classic cases and cutting-edge technologies in related specialties.

This conference provides a platform for the exchange of diagnosis and treatment technology and academic scientific research achievements for the majority of clinical doctors and scientific research workers, which is conducive to promoting the academic development of clinical research and medical head and neck oncology, and is of great significance for promoting high-quality clinical research and promoting the level of clinical research in the field of medical liver cancer oncology.